Variables associated with contrast-enhanced cardiovascular magnetic resonance in hypertrophic cardiomyopathy:

Eduardo Payá1, Francisco Marín, Josefa González

  • 1Department of Cardiology, Hospital General Universitario, Alicante, Spain.

Insights

Late gadolinium enhancement (LGE) is common in hypertrophic cardiomyopathy (HCM) and linked to increased wall thickness and ventricular tachycardia. LGE also correlates with more sudden cardiac death risk factors in HCM patients.

Area of Science:

  • Cardiology
  • Medical Imaging

Background:

  • Hypertrophic cardiomyopathy (HCM) is characterized by increased myocardial collagen and disarray.
  • Late gadolinium enhancement (LGE) in cardiovascular magnetic resonance (CMR) visualizes myocardial scarring, often in HCM.
  • LGE extent in HCM is linked to increased risk factors for sudden cardiac death.

Purpose of the Study:

  • To characterize clinical features and sudden death risk factors in HCM patients.
  • To investigate the relationship between LGE on CMR and these clinical factors.

Main Methods:

  • 120 HCM patients underwent clinical evaluation and CMR with LGE assessment.
  • Risk factors for sudden death, exercise capacity, and NT-proBNP levels were analyzed.
  • Multivariate analysis identified predictors of LGE.

Main Results:

  • 69% of patients showed LGE.
  • LGE patients had greater left ventricular wall thickness, more frequent obstruction, and nonsustained ventricular tachycardia.
  • LGE was associated with worse exercise capacity, higher NT-proBNP, and a greater number of sudden death risk factors.

Conclusions:

  • Late gadolinium enhancement is a frequent finding in hypertrophic cardiomyopathy.
  • Increased maximal left ventricular wall thickness and nonsustained ventricular tachycardia are associated with LGE.
  • LGE in HCM correlates with elevated risk factors for sudden death and impaired functional status.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Imaging Studies for Cardiovascular System IV: CMRI01:21

Imaging Studies for Cardiovascular System IV: CMRI

Cardiovascular magnetic resonance imaging, or CMRI, is a non-invasive diagnostic test that employs a magnetic field and radiofrequency waves to create precise images of the heart and arteries. It provides comprehensive information about cardiac anatomy, function, perfusion, and tissue characterization without ionizing radiation.IndicationsCMRI diagnoses various heart conditions, including tissue damage from heart attacks, ischemic heart disease, myocarditis, aortic issues (tears, aneurysms,...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...